📋 Tender Overview
Contract awarded for Centralized framework agreement for 24 months for the supply of medicines xiii/2024 { "detected_language": "romanian", "translated_text": "lot-0011, title: ampicillin type combinations atb 500 mg ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0021, title: cefalexin type combinations atb 500 mg ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0022, title: cefalexin type combinations atb 250 mg ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0024, title: dermovate cream type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0025, title: codeine phosphate lph 15 mg type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0040, title: erdomed type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0059, title: kanamycin sulfate type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0077, title: algifen type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0092, title: oxacillin 250 mg type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0110, title: coaxil 12.5 mg type combinations or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0119, title: dexatobrom sol. oft. type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0137, title: zinnat type combinations ® or equivalent, description: product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0141, title: arginine-sorbitol 50 mg/ml + 100 mg/ml type combinations or equivalent 250 ml, description: product estimated value excluding vat: 1740.00 ron.Centralized framework agreement for 24 months for the supply of medicines xiii/2024
